MTBC: Medical Transcription Billing, Corp. is a Buy

The current rating for MTBC is 67, which is 34% above its historic median rating of 50. This indicates lower risk than normal.

The rating is currently showing a higher than normal reading, suggesting risk levels could be lower than normal.